The Second paediatric strategy forum, Medicinal Product Development for Mature B cell Malignancies in Children, jointly organised by ACCELERATE and the European Medicines Agency (EMA), will be held in London at the EMA premises on 13 and 14 November​, 2017.

The event will focus on mature B cell malignancies (lymphoma and leukaemia) in children and is aimed to share information, in a pre-competitive setting, which will inform a paediatric drug development strategy and subsequent decisions and facilitate the developments of innovative medicines for the treatment of children with B cell malignancies.

More information on the objectives of this forum and link to the expressions of interest forms can be found on the EMA website: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2017/06/event_detail_001453.jsp&mid=WC0b01ac058004d5c3

And in the ACCELERATE website: http://www.accelerate-platform.eu/annual-conferences-2/upcoming-events/paediatric_strategy_forum/

Deadline to submit expressions of interest is 30 June​, 2017​.

Related Posts